Coronavirus (Covid-19) vaccine May update: Moderna’s clinical trial enters phase II; Sinovac 99% sure of vaccine efficacy

Coronavirus (Covid-19) vaccine latest update: With developing a safe, effective and accessible vaccine for Covid-19 being seen as the key to contain the pandemic, research and trials are going on at a fast pace across the world to find a cure for the novel coronavirus.

In latest developments, US company Moderna Inc, one of the front runners in the vaccine race, has said it had started dosing patients in a mid-stage study while Russian scientists plan to start clinical trials within two weeks.

Around 120 vaccines are in the works across the world, of which at least 10 are undergoing human trials even as cases worldwide crossed the 61 lakh mark, including 372,566 deaths. Till date, China’s CanSino adenovirus vaccine, Oxford University’s adenovirus vaccine, Moderna’s mRNA vaccine and Novavax have emerged as the top most promising vaccine candidates for Covid-19.Coming to India, where cases touched 1,82,143 on Sunday after reporting 8,380 new infections in 24 hours,Baba Ramdev’s Patanjali group has joined the global efforts of developing a cure for Covid-19, PTI reported.